Search
for
Sort by
Research 571–600 of 1000+
- Twenty-Nail Dystrophy Treated with Hydroxychloroquine in a Patient with Alopecia Areata
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Increase in IL-15 levels in patients with alopecia areata
- Alopecia Areata in 12 years old female treated with Oral Azathioprine: A case report and review
- 490 Samcyprone (diphenylcyclopropenone ointment) for the treatment of common warts
- Primary cicatricial alopecias
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Multiple minute digitate hyperkeratosis
- Efluvio anágeno. Hallazgos tricoscópicos
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Alopecia Areata
- Cutaneous Reactions to Drugs
- Assessment of chemokines MIP-1α and MIP-1 βin Iraqi women with polycystic ovarian syndrome
- Systemic corticosteroids in vitiligo: Evidence-based insights and practical considerations
- Total Glucosides of Paeony Capsule Plus Compound Glycyrrhizin Tablets for the Treatment of Severe Alopecia Areata in Children: A Randomized Controlled Trial
- Platelet Immune Interactions, Lifespan, and Senescence
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- An Overview of Alopecias
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Alopecia Areata: Current Review
- Alopecia and Thyroid Disease
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Alopecia Areata
- Assessment of Interleukin-17A and Interleukin-2 Serum Levels in Patients with Alopecia Areata
- Cancer risk by the subtype of alopecia
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Zinc: A complementary factor in the treatment of chronic hepatitis C? (Review)
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Modern Management Approaches for Alopecia Areata